Summary: During this Q&A, we discuss the challenges of mRNA development and manufacturing, potential solutions and where the industry may go next with mRNA therapies.

Summary: In this executive summary, Catalent Biologics offers advice to pharma companies on three key areas of auto-injector device development.

Summary: During this talk, hear the latest data leveraging GPEx Lightning to generate highly stable, highly productive cell pools and discuss how the GPEx...

Summary: During this presentation, experts will discuss the latest challenges in biophysical characterization and will present solutions to overcome these challenges.

Summary: Catalent Biologics’ drug product operations in Europe can formulate, fill and finish sterile products into a vial, syringe, or cartridge injectable format for clinical and...

Summary: Learn factors that drive the emergence of complex, protein-based biologics, areas in which these molecules are experiencing the fastest growth, and challenges in their development and advancement to the clinic.

Summary: This will be Endpoints’ 2021 look at 11 of the most important up-and-coming private biotechs in the business, independently selected by company founder and editor John Carroll.

Summary: This webinar summarizes the current bioanalytical landscape and its challenges, and discusses strategies to overcome them.

Summary: In this webinar, key leaders in the field talk about where this is headed, and how it may more broadly affect everyone doing antibody research and development.

Summary: Plasmid DNA is a critical raw material for cell and gene therapies. Discover the importance of having an integrated partner like Catalent Cell & Gene, and how we can keep your development and manufacturing on track and on schedule.